Results 191 to 200 of about 38,667 (276)

Accelerating Generic Long‐Acting Antiretrovirals for Global HIV Treatment: Workshop Findings and a Roadmap to Access

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
The global HIV response aims for widespread availability of affordable, quality‐assured long‐acting antiretroviral (LA ARV) drugs to achieve sustained epidemic control, particularly in low‐ and middle‐income countries. This report summarizes key discussion points, findings, and outcomes from an international workshop on generic LA ARVs, held in ...
Usman Arshad   +22 more
wiley   +1 more source

Bivalent SMAC mimetic APG-1387 reduces HIV reservoirs and limits viral rebound in humanized mice. [PDF]

open access: yesiScience
Jain J   +12 more
europepmc   +1 more source

Drug Washout and Viral Rebound: Modeling HIV Reactivation Under ART Discontinuation

open access: yes
Due to the persistence of latently infected CD4+T cells, achieving a functional cure for HIV-1 remains a significant challenge since the viruses are able to evade immune clearance, which in turn enables post-treatment viral rebound. Because traditional deterministic models assume a constant reactivation rate, they fail to capture the stochastic nature ...
openaire   +2 more sources

Product‐Related CSR in the Digital Era: Communication Patterns That Drive Consumer Interactions on Social Media

open access: yesCorporate Social Responsibility and Environmental Management, EarlyView.
ABSTRACT To meet rising sustainability demands, companies increasingly use social media to communicate product‐related CSR initiatives. Consumers' interactions with these messages largely depend on the messages' perceived credibility. However, there remains limited understanding of how firms combine communication characteristics into distinct patterns ...
Judith Derenthal, Waldemar Toporowski
wiley   +1 more source

Suppression of viral rebound by a Rev-dependent lentiviral particle in SIV-infected rhesus macaques. [PDF]

open access: yesGene Ther
Hetrick B   +13 more
europepmc   +1 more source

Do ESG‐Related Managerial Capabilities Pay Off for SMEs? Evidence From the Small and Medium‐Sized Enterprise ESG Capability Measure (SM‐ESG)

open access: yesCorporate Social Responsibility and Environmental Management, EarlyView.
ABSTRACT Large companies have a long track record of environmental, social, and governance (ESG) initiatives, whereas many small and medium‐sized enterprises (SMEs) lag in adopting sustainability‐related practices, often acting voluntarily or in response to stakeholder pressures and incentives.
Vivien Csapi   +4 more
wiley   +1 more source

Author Correction: Dual blockade of IL-10 and PD-1 leads to control of SIV viral rebound following analytical treatment interruption. [PDF]

open access: yesNat Immunol
Pereira Ribeiro S   +29 more
europepmc   +1 more source

Powerful yet challenging: mechanistic niche models for predicting invasive species potential distribution under climate change

open access: yesEcography, EarlyView.
Risk assessments of invasive species present one of the most challenging applications of species distribution models (SDMs) due to the fundamental issues of distributional disequilibrium, niche changes, and truncation. Invasive species often occupy only a fraction of their potential environmental and geographic ranges, as their spatiotemporal dynamics ...
Erola Fenollosa   +4 more
wiley   +1 more source

Safety, immunogenicity and effect on viral rebound of HTI vaccines combined with a TLR7 agonist in early-treated HIV-1 infection: a randomized, placebo-controlled phase 2a trial. [PDF]

open access: yesNat Commun
Bailón L   +38 more
europepmc   +1 more source

Viral rebound among patients receiving COVID-19 convalescent plasma for treatment of Covid-19 in Uganda

open access: yes, 2023
Alupo P   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy